Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call by mparnell | Mar 4, 2019 | Portfolio News
Axonics® Appoints Michael H. Carrel to its Board of Directors by mparnell | Mar 4, 2019 | Portfolio News
Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights by mparnell | Feb 28, 2019 | Portfolio News
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019 by mparnell | Feb 27, 2019 | Portfolio News
Axonics® Submits Pivotal Clinical Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System by mparnell | Feb 26, 2019 | Portfolio News